Tag: Trial
New Clinical Trial Proves Allen Carr's Easyway to Stop Smoking Seminars Are at Least as Effective as the UK's Gold Standard NHS Stop Smoking Serv

New Clinical Trial Proves Allen Carr's Easyway to Stop Smoking Seminars Are at Least as Effective as the UK's Gold Standard NHS Stop Smoking Serv

LONDON, Jan. 23, 2020 /PRNewswire/ -- The largest and most authoritative research trial of its kind has confirmed that Allen Carr's Easyway (ACE) is now a clinically proven, ...

Lees verder
Panaxia Announces Positive Top-Line Results From Its Clinical Trial In Leading Medical Cannabis Products

Panaxia Announces Positive Top-Line Results From Its Clinical Trial In Leading Medical Cannabis Products

Results demonstrate efficacy of absorption in the blood and safety of tablets, suppositories and inhaled cannabis extract In addition, data show that Panaxia's sublingual ...

Lees verder
Adagio Medical Announces First Patient Enrollment in its iCLAS(TM) U.S. IDE Clinical Trial Evaluating Ultra-Low Temperature Cryoablation for Pers

Adagio Medical Announces First Patient Enrollment in its iCLAS(TM) U.S. IDE Clinical Trial Evaluating Ultra-Low Temperature Cryoablation for Pers

LAGUNA HILLS, California, Dec. 17, 2019 /PRNewswire/ -- Adagio Medical, Inc. (Adagio) today announced it has enrolled the first patient in its iCLAS(TM) Investigational Device ...

Lees verder
Nuvaira Receives French Innovation Funding for AIRFLOW-3 Pivotal Trial

Nuvaira Receives French Innovation Funding for AIRFLOW-3 Pivotal Trial

Novel program provides reimbursement for TLD therapy in France MINNEAPOLIS, May 2, 2019 /PRNewswire/ -- Nuvaira , developer of novel therapeutic strategies to treat ...

Lees verder
Merck and Pfizer Provide Update on JAVELIN Ovarian 100 Trial of Avelumab in Previously Untreated Advanced Ovarian Cancer

Merck and Pfizer Provide Update on JAVELIN Ovarian 100 Trial of Avelumab in Previously Untreated Advanced Ovarian Cancer

DARMSTADT, Germany and NEW YORK, December 21, 2018 /PRNewswire/ -- Not intended for US, Canada and UK-based media   Merck and Pfizer Inc. today announced that data from a ...

Lees verder
Micro Interventional Devices, Inc.(TM) Announces Continued Successful Enrollment in STTAR Trial

Micro Interventional Devices, Inc.(TM) Announces Continued Successful Enrollment in STTAR Trial

Three additional patients treated with 12F Percutaneous MIA((TM)), Minimally Invasive Annuloplasty, Technology NEWTOWN, Pennsylvania, Nov. 29, 2018 /PRNewswire/ -- Micro ...

Lees verder
AAIC® 2018 Features First Clinical Trial to Show Intensive Blood Pressure Treatment Reduces New Cases of Mild Cognitive Impairment and Dementia (

AAIC® 2018 Features First Clinical Trial to Show Intensive Blood Pressure Treatment Reduces New Cases of Mild Cognitive Impairment and Dementia (

CONFERENCE ALSO RELEASES FIRST-EVER DEMENTIA DATA IN LGB SENIORS, AND WOMEN'S DEMENTIA RISK RELATED TO REPRODUCTIVE HISTORY CHICAGO, July 25, 2018 /PRNewswire/ -- The first ...

Lees verder
ENDOSCOPY Publishes the MORA Phase III Trial for PLENVU® (NER1006), the Only 1 Litre Peg Based Bowel Preparation[i]

ENDOSCOPY Publishes the MORA Phase III Trial for PLENVU® (NER1006), the Only 1 Litre Peg Based Bowel Preparation[i]

AMSTERDAM, July 19, 2018 /PRNewswire/ -- Norgine B.V. today announced that results from the PLENVU(R) Phase III MORA trial were published in ENDOSCOPY, a monthly peer-reviewed ...

Lees verder
Results From Pivotal Phase 3 PROSPER Trial of XTANDI[TM] (enzalutamide) in Men With Non-Metastatic Castration-Resistant Prostate Cancer Published

Results From Pivotal Phase 3 PROSPER Trial of XTANDI[TM] (enzalutamide) in Men With Non-Metastatic Castration-Resistant Prostate Cancer Published

TOKYO, June 29, 2018 /PRNewswire/ -- Results show enzalutamide plus androgen deprivation therapy significantly reduced the risk of developing metastases or death by 71 ...

Lees verder
Oral Semaglutide Demonstrated Significant Reduction in Blood Sugar vs Placebo in PIONEER 1 Trial

Oral Semaglutide Demonstrated Significant Reduction in Blood Sugar vs Placebo in PIONEER 1 Trial

ORLANDO, Florida, June 23, 2018 /PRNewswire/ -- Oral semaglutide, an investigational GLP-1 analogue taken as a once-daily tablet, achieved significant reductions in blood ...

Lees verder
BizPress.nl